Sofinnova Investments

Sofinnova Investments company information, Employees & Contact Information

Sofinnova Investments is a healthcare investment firm committed to funding innovative products that aspire to meaningfully impact the lives of patients. We invest in both private and public equity companies. Sofinnova actively partners with entrepreneurs across all stages of company formation, we are long-term investors with extensive scientific expertise, vast industry knowledge, and a track record of helping forge the path from drug development and navigating the regulatory process to company building and IPO or M&A. Founded in 1976, Sofinnova has a long legacy of building what we believe are great companies in both the U.S. and Europe with approximately $3.3B in assets under management and committed capital as of 6/30/2024.

Company Details

Employees
57
Founded
-
Address
3000 Sand Hill Rd 4-250,
Phone
+1 650 322 2037
Email
in****@****ova.com
Industry
Investment Management
NAICS
Other Financial Investment Activities
Portfolio Management
All Other Financial Investment Activities
Trust, Fiduciary, and Custody Activities
Miscellaneous Financial Investment Activities
HQ
Menlo Park, CA
Looking for a particular Sofinnova Investments employee's phone or email?

Sofinnova Investments Questions

News

Sofinnova Partners Raises €1.2 Billion to Fuel the Next Wave of Life Sciences Innovation - Business Wire

Sofinnova Partners Raises €1.2 Billion to Fuel the Next Wave of Life Sciences Innovation Business Wire

How Sofinnova Partners orchestrated a biotech comeback - BioXconomy

How Sofinnova Partners orchestrated a biotech comeback BioXconomy

Sofinnova secures €1.2B for new biotech investments - BioPharma Dive

Sofinnova secures €1.2B for new biotech investments BioPharma Dive

VC Firm Sofinnova Partners Pulls In €1.2B to Deploy Across Life Sciences Investments - MedCity News

VC Firm Sofinnova Partners Pulls In €1.2B to Deploy Across Life Sciences Investments MedCity News

Sofinnova closes €165M European biotech acceleration fund - Fierce Biotech

Sofinnova closes €165M European biotech acceleration fund Fierce Biotech

Sofinnova has €1.2B to invest in up to 60 new life sciences firms - FirstWord Pharma

Sofinnova has €1.2B to invest in up to 60 new life sciences firms FirstWord Pharma

Paris-based Sofinnova Partners raises €1.2B, surpasses €4B in AUM - Silicon Canals

Paris-based Sofinnova Partners raises €1.2B, surpasses €4B in AUM Silicon Canals

Sofinnova Partners Exceeds Target With €165M Biotech Acceleration Fund, Europe’s Largest, With Strong Pharma Support - Business Wire

Sofinnova Partners Exceeds Target With €165M Biotech Acceleration Fund, Europe’s Largest, With Strong Pharma Support Business Wire

VC firm Sofinnova brings in €1.2B over a year to fund up to 60 life sciences companies - Fierce Biotech

VC firm Sofinnova brings in €1.2B over a year to fund up to 60 life sciences companies Fierce Biotech

Sofinnova’s latest biotech fund sprouts three new startups - BioPharma Dive

Sofinnova’s latest biotech fund sprouts three new startups BioPharma Dive

Sofinnova and Medicxi talk M&A, patent cliffs, and China - BioXconomy

Sofinnova and Medicxi talk M&A, patent cliffs, and China BioXconomy

Sofinnova Investments Announces the Addition of Industry Veteran Maha Katabi, PhD. as a Partner - PR Newswire

Sofinnova Investments Announces the Addition of Industry Veteran Maha Katabi, PhD. as a Partner PR Newswire

Capital Growth: Sofinnova Invests in Digital Medicine - Genetic Engineering and Biotechnology News

Capital Growth: Sofinnova Invests in Digital Medicine Genetic Engineering and Biotechnology News

Sofinnova taps NVIDIA to bolster portfolio companies’ computational power - Medical Device Network

Sofinnova taps NVIDIA to bolster portfolio companies’ computational power Medical Device Network

Biotech Investor Sofinnova Investments Adds Executive Partner - The Wall Street Journal

Biotech Investor Sofinnova Investments Adds Executive Partner The Wall Street Journal

Sofinnova Investments Announces the Addition of Dr. Maha Radhakrishnan as Executive Partner - Business Wire

Sofinnova Investments Announces the Addition of Dr. Maha Radhakrishnan as Executive Partner Business Wire

Sofinnova Announces the Addition of Industry Leader Alan Colowick, MD, MPH to its Partnership - PR Newswire

Sofinnova Announces the Addition of Industry Leader Alan Colowick, MD, MPH to its Partnership PR Newswire

Sofinnova Partners Raises $200M Digital Medicine Fund - Business Wire

Sofinnova Partners Raises $200M Digital Medicine Fund Business Wire

Sofinnova Investments Appoints Dr. Jakob Dupont as Executive Partner - Business Wire

Sofinnova Investments Appoints Dr. Jakob Dupont as Executive Partner Business Wire

Sofinnova Welcomes Agnès Pauquet as Head of Human Resources - Business Wire

Sofinnova Welcomes Agnès Pauquet as Head of Human Resources Business Wire

Sofinnova Partners raises €1.2 B in funding - World Bio Market Insights

Sofinnova Partners raises €1.2 B in funding World Bio Market Insights

Sofinnova Ventures Adds Daniel G. Welch to Life Science Investing Team - PR Newswire

Sofinnova Ventures Adds Daniel G. Welch to Life Science Investing Team PR Newswire

Sofinnova Partners closes €165m Biovelocita II biotech acceleration fund - European Biotechnology Magazine

Sofinnova Partners closes €165m Biovelocita II biotech acceleration fund European Biotechnology Magazine

French VC Raises the Biggest Green Biotech Fund in the World - Labiotech.eu

French VC Raises the Biggest Green Biotech Fund in the World Labiotech.eu

€165 million for biotech: Sofinnova Partners concludes its Biovelocita II fund, receiving support from Amgen, Bristol Myers Squibb, and Pfizer Ventures - Tech Funding News

€165 million for biotech: Sofinnova Partners concludes its Biovelocita II fund, receiving support from Amgen, Bristol Myers Squibb, and Pfizer Ventures Tech Funding News

Sofinnova Announces the Addition of Industry Veteran Sunil Agarwal, MD to its Partnership - PR Newswire

Sofinnova Announces the Addition of Industry Veteran Sunil Agarwal, MD to its Partnership PR Newswire

Biogen CMO Maha Radhakrishnan joins Sofinnova—Chutes & Ladders - Fierce Biotech

Biogen CMO Maha Radhakrishnan joins Sofinnova—Chutes & Ladders Fierce Biotech

VC firm Sofinnova banks $1B from Apollo to invest in early-stage biotech solutions - Fierce Biotech

VC firm Sofinnova banks $1B from Apollo to invest in early-stage biotech solutions Fierce Biotech

Europe’s largest: Sofinnova Partners bags $180m biotech acceleration fund - BioXconomy

Europe’s largest: Sofinnova Partners bags $180m biotech acceleration fund BioXconomy

Sofinnova Partners Closes $540M Oversubscribed Late-Stage Healthcare Crossover Fund - Private Equity Insights

Sofinnova Partners Closes $540M Oversubscribed Late-Stage Healthcare Crossover Fund Private Equity Insights

Sofinnova Partners Appoints Mats Eklund as Partner and Chief Operating Officer - Business Wire

Sofinnova Partners Appoints Mats Eklund as Partner and Chief Operating Officer Business Wire

Sofinnova Partners and Apollo Form Strategic Partnership in Life Sciences - Business Wire

Sofinnova Partners and Apollo Form Strategic Partnership in Life Sciences Business Wire

Investing For Life: Q&A With Sofinnova Chairman Antoine Papiernik - Global Finance Magazine

Investing For Life: Q&A With Sofinnova Chairman Antoine Papiernik Global Finance Magazine

Sofinnova Partners, NVIDIA Team Up for Life Science Innovation - Medical Product Outsourcing

Sofinnova Partners, NVIDIA Team Up for Life Science Innovation Medical Product Outsourcing

Stanford Biodesign co-founder joins Sofinnova Partners - MassDevice

Stanford Biodesign co-founder joins Sofinnova Partners MassDevice

Sofinnova Partners Raises €1.2 Billion for Life Sciences Investments; Surpasses €4 Billion in AUM - Femtech Insider

Sofinnova Partners Raises €1.2 Billion for Life Sciences Investments; Surpasses €4 Billion in AUM Femtech Insider

Sofinnova invests in Abivax to delay cash crunch - Fierce Biotech

Sofinnova invests in Abivax to delay cash crunch Fierce Biotech

Endoron Medical raises $10 Million in Series A funding led by Sofinnova Partners to accelerate the validation of its AAA EndoStapling solution Aortoseal - Business Wire

Endoron Medical raises $10 Million in Series A funding led by Sofinnova Partners to accelerate the validation of its AAA EndoStapling solution Aortoseal Business Wire

Aerovate Therapeutics Emerges From RA Capital Incubator - GlobeNewswire

Aerovate Therapeutics Emerges From RA Capital Incubator GlobeNewswire

Sofinnova: Here's the 14-Slide Pitch Deck the VC Used to Raise $170m - businessinsider.com

Sofinnova: Here's the 14-Slide Pitch Deck the VC Used to Raise $170m businessinsider.com

SEC fines Sofinnova Ventures for pay-to-play violations - Buyouts

SEC fines Sofinnova Ventures for pay-to-play violations Buyouts

Sofinnova raises Europe’s largest early-stage healthcare fund with €472m - Sifted

Sofinnova raises Europe’s largest early-stage healthcare fund with €472m Sifted

Natera, Inc., Non-Invasive Genetic Testing Leader, Secures $55 Million in Private Financing - PR Newswire

Natera, Inc., Non-Invasive Genetic Testing Leader, Secures $55 Million in Private Financing PR Newswire

Techwork 2024: Stéphanie Huiban, Sofinnova Partners - The Drawdown

Techwork 2024: Stéphanie Huiban, Sofinnova Partners The Drawdown

Natera raises $55.5 million in funding led by Sofinnova Ventures - News-Medical

Natera raises $55.5 million in funding led by Sofinnova Ventures News-Medical

Sofinnova Partners launches $340m healthcare crossover fund - MassDevice

Sofinnova Partners launches $340m healthcare crossover fund MassDevice

Sofinnova Partners closes digital medicine fund - EU.COM

Sofinnova Partners closes digital medicine fund EU.COM

Sofinnova Partners Raises €150M for Sofinnova Industrial Biotech II - Global AgInvesting

Sofinnova Partners Raises €150M for Sofinnova Industrial Biotech II Global AgInvesting

Sofinnova secures €106 million biotech fund - Bioökonomie.de

Sofinnova secures €106 million biotech fund Bioökonomie.de

SARcode Bioscience Completes $44 Million Series B Financing - PR Newswire

SARcode Bioscience Completes $44 Million Series B Financing PR Newswire

David Hytha joins Sofinnova Ventures - Mobile Industry Review

David Hytha joins Sofinnova Ventures Mobile Industry Review

Top Sofinnova Investments Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant